LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis

NASDAQ:LMAT • US5255582018

92.94 USD
+1.08 (+1.18%)
At close: Feb 20, 2026
92.94 USD
0 (0%)
After Hours: 2/20/2026, 4:30:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LMAT a very profitable company, without any liquidiy or solvency issues. LMAT has a correct valuation and a medium growth rate. With these ratings, LMAT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • LMAT had positive earnings in the past year.
  • LMAT had a positive operating cash flow in the past year.
  • In the past 5 years LMAT has always been profitable.
  • Each year in the past 5 years LMAT had a positive operating cash flow.
LMAT Yearly Net Income VS EBIT VS OCF VS FCFLMAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • With an excellent Return On Assets value of 8.92%, LMAT belongs to the best of the industry, outperforming 91.35% of the companies in the same industry.
  • LMAT has a better Return On Equity (14.08%) than 90.27% of its industry peers.
  • LMAT's Return On Invested Capital of 8.43% is amongst the best of the industry. LMAT outperforms 87.03% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 8.75%.
  • The 3 year average ROIC (8.26%) for LMAT is below the current ROIC(8.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.92%
ROE 14.08%
ROIC 8.43%
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
LMAT Yearly ROA, ROE, ROICLMAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 22.14%, LMAT belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
  • In the last couple of years the Profit Margin of LMAT has grown nicely.
  • With an excellent Operating Margin value of 25.71%, LMAT belongs to the best of the industry, outperforming 95.14% of the companies in the same industry.
  • LMAT's Operating Margin has improved in the last couple of years.
  • LMAT has a better Gross Margin (70.97%) than 80.54% of its industry peers.
  • In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
Industry RankSector Rank
OM 25.71%
PM (TTM) 22.14%
GM 70.97%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
LMAT Yearly Profit, Operating, Gross MarginsLMAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
  • The number of shares outstanding for LMAT has been increased compared to 1 year ago.
  • Compared to 5 years ago, LMAT has more shares outstanding
  • LMAT has a worse debt/assets ratio than last year.
LMAT Yearly Shares OutstandingLMAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
LMAT Yearly Total Debt VS Total AssetsLMAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 7.70 indicates that LMAT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 7.70, LMAT belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
  • LMAT has a debt to FCF ratio of 2.54. This is a good value and a sign of high solvency as LMAT would need 2.54 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 2.54, LMAT belongs to the best of the industry, outperforming 84.32% of the companies in the same industry.
  • LMAT has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • LMAT has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 2.54
Altman-Z 7.7
ROIC/WACC0.85
WACC9.96%
LMAT Yearly LT Debt VS Equity VS FCFLMAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • LMAT has a Current Ratio of 13.58. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
  • LMAT has a Current ratio of 13.58. This is amongst the best in the industry. LMAT outperforms 97.84% of its industry peers.
  • LMAT has a Quick Ratio of 11.45. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
  • LMAT has a better Quick ratio (11.45) than 95.68% of its industry peers.
Industry RankSector Rank
Current Ratio 13.58
Quick Ratio 11.45
LMAT Yearly Current Assets VS Current LiabilitesLMAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.67%, which is quite good.
  • The Earnings Per Share has been growing by 17.13% on average over the past years. This is quite good.
  • The Revenue has grown by 13.07% in the past year. This is quite good.
  • Measured over the past years, LMAT shows a quite strong growth in Revenue. The Revenue has been growing by 13.41% on average per year.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.10% on average over the next years. This is quite good.
  • Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.65% on average per year.
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LMAT Yearly Revenue VS EstimatesLMAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
LMAT Yearly EPS VS EstimatesLMAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • LMAT is valuated quite expensively with a Price/Earnings ratio of 42.44.
  • Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.27% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (27.09), we can say LMAT is valued expensively.
  • With a Price/Forward Earnings ratio of 35.22, LMAT can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 69.73% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.98, LMAT is valued a bit more expensive.
Industry RankSector Rank
PE 42.44
Fwd PE 35.22
LMAT Price Earnings VS Forward Price EarningsLMAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 74.59% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than the industry average as 77.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 31.84
EV/EBITDA 22.04
LMAT Per share dataLMAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as LMAT's earnings are expected to grow with 14.06% in the coming years.
PEG (NY)1.54
PEG (5Y)2.48
EPS Next 2Y16.63%
EPS Next 3Y14.06%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.92%, LMAT is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.20, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.89% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, LMAT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.92%

5.2 History

  • On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
  • LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
LMAT Yearly Dividends per shareLMAT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • LMAT pays out 32.20% of its income as dividend. This is a sustainable payout ratio.
  • LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
LMAT Yearly Income VS Free CF VS DividendLMAT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LMAT Dividend Payout.LMAT Dividend Payout, showing the Payout Ratio.LMAT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

LEMAITRE VASCULAR INC

NASDAQ:LMAT (2/20/2026, 4:30:02 PM)

After market: 92.94 0 (0%)

92.94

+1.08 (+1.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners95.2%
Inst Owner Change7.97%
Ins Owners7.98%
Ins Owner Change0.64%
Market Cap2.11B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price Target105.74 (13.77%)
Short Float %5.52%
Short Ratio7.45
Dividend
Industry RankSector Rank
Dividend Yield 0.92%
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.93%
EPS NY rev (1m)0%
EPS NY rev (3m)6.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.94%
Valuation
Industry RankSector Rank
PE 42.44
Fwd PE 35.22
P/S 8.76
P/FCF 31.84
P/OCF 28.78
P/B 5.57
P/tB 7.5
EV/EBITDA 22.04
EPS(TTM)2.19
EY2.36%
EPS(NY)2.64
Fwd EY2.84%
FCF(TTM)2.92
FCFY3.14%
OCF(TTM)3.23
OCFY3.47%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.54
PEG (5Y)2.48
Graham Number28.69
Profitability
Industry RankSector Rank
ROA 8.92%
ROE 14.08%
ROCE 10.97%
ROIC 8.43%
ROICexc 21.47%
ROICexgc 38.36%
OM 25.71%
PM (TTM) 22.14%
GM 70.97%
FCFM 27.5%
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 2.54
Debt/EBITDA 2.33
Cap/Depr 68.51%
Cap/Sales 2.93%
Interest Coverage 250
Cash Conversion 101.46%
Profit Quality 124.17%
Current Ratio 13.58
Quick Ratio 11.45
Altman-Z 7.7
F-Score5
WACC9.96%
ROIC/WACC0.85
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.49%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year47.11%
EBIT Next 3Y23.04%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%

LEMAITRE VASCULAR INC / LMAT FAQ

What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LMAT.


What is the valuation status of LEMAITRE VASCULAR INC (LMAT) stock?

ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.


How profitable is LEMAITRE VASCULAR INC (LMAT) stock?

LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.


What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 42.44 and the Price/Book (PB) ratio is 5.57.


How financially healthy is LEMAITRE VASCULAR INC?

The financial health rating of LEMAITRE VASCULAR INC (LMAT) is 7 / 10.